Granulation lines for research and development, takes the process from dispensed raw materials to finished tablet. Our systems clearly demonstrates the flexibility that can be achieved throughout the process – including high shear granulation, pelletizing and blending, etc.
All technologies can be brought together in an integrated process system that mimics the hundreds of large-scale plants provided by GEA globally. It epitomizes the approach of ensuring customers receive the same technology from the laboratory through to production, using the same containment and process technologies to ensure seamless scale-up and the most flexible blend of process capabilities.
Weergegeven 4 van 8

Committed to providing flexible, modular equipment to support research and development in the pharmaceutical industry, the multipurpose AirConnect from GEA delivers a range of fluid bed processing solutions for small-scale applications.

The ConsiGma® 1 offers standalone continuous twin-screw granulation and drying for small-scale R&D operations. It allows users to develop the process and achieve high granule quality on a compact unit.

The ConsiGma® CF20 test rig is a standalone module that allows you to characterize the feeding behavior of your products during the early stages of R&D.

An indispensable part of the ConsiGma portfolio, the Conductor control system architecture ensures smooth operation and communication between the different elements of a pharmaceutical continuous manufacturing line

Van de industriële productie wordt verwacht dat ze minder grondstoffen verbruikt, slimmer te werk gaat en ervoor zorgt dat apparatuur langer productief blijft. Bij GEA verandert dit de manier waarop innovatie tot stand komt: techniek, klantinzicht, digitale expertise en service worden al in een vroeger stadium gebundeld, namelijk op het moment dat de kern van een oplossing nog vorm kan krijgen.